Patents by Inventor David F. Silver

David F. Silver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150406
    Abstract: Charged nutritive proteins are provided. In some embodiments the nutritive proteins an aqueous solubility of at least 12.5 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 50 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 100 g/L at pH 7.
    Type: Application
    Filed: October 10, 2023
    Publication date: May 9, 2024
    Inventors: David Arthur Berry, Brett Adam Boghigian, Nathaniel W. Silver, Geoffrey von Maltzahn, Michael Hamill, Rajeev Chillakuru, John F. Kramarczyk
  • Patent number: 6620779
    Abstract: A method for enhancing the effect of anti-tumor agents on solid tumors is provided. The method comprises administering to an individual an anti-tumor agent and a hematocrit elevator. The hematocrit elevator may be administered before or concurrently with the anti-tumor agent.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: September 16, 2003
    Assignee: Health Research Inc.
    Inventors: M. Steven Piver, David F. Silver
  • Publication number: 20020198153
    Abstract: A method for enhancing the effect of anti-tumor agents on solid tumors is provided. The method comprises administering to an individual an anti-tumor agent and a hematocrit elevator. The hematocrit elevator may be administered before or concurrently with the anti-tumor agent.
    Type: Application
    Filed: July 26, 2002
    Publication date: December 26, 2002
    Inventors: M. Steven Piver, David F. Silver
  • Patent number: 6426094
    Abstract: A method for enhancing the effect of anti-tumor agents on solid tumors is provided. The method comprises administering to an individual an anti-tumor agent and a hematocrit elevator. The hematocrit elevator may be administered before or concurrently with the anti-tumor agent.
    Type: Grant
    Filed: December 19, 2000
    Date of Patent: July 30, 2002
    Assignee: Health Research, Inc.
    Inventors: M. Steven Piver, David F. Silver
  • Publication number: 20010000730
    Abstract: A method for enhancing the effect of anti-tumor agents on solid tumors is provided. The method comprises administering to an individual an anti-tumor agent and a hematocrit elevator. The hematocrit elevator may be administered before or concurrently with the anti-tumor agent.
    Type: Application
    Filed: December 19, 2000
    Publication date: May 3, 2001
    Inventors: M. Steven Piver, David F. Silver
  • Patent number: 6171620
    Abstract: A method for enhancing the effect of anti-tumor agents on solid tumors is provided. The method comprises administering to an individual an anti-tumor agent and a hematocrit elevator. The hematocrit elevator may be administered before or concurrently with the anti-tumor agent.
    Type: Grant
    Filed: April 27, 1999
    Date of Patent: January 9, 2001
    Assignee: Health Research, Inc.
    Inventors: M. Steven Piver, David F. Silver